Biggest News Aggregation in the World
📰 Interim Statement News

Page 22 - Interim Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Interim Statement. Real-time updates on events, politics, business and more.

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Financial Results for the First Quarter of 2021 and Provides Corporate Update

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Quarter Results/Quarterly / Interim Statement Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Financial Results for the First
Noord Holland Halle Saale Gretchen Schweitzer Valeria Fisher Philip Scheltens Manuela Bader Ulrich Dauer

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

HAEMATO AG with strong start to the year: EBIT rises in Q1 by 350 % to EUR 2.4 million and revenues

DGAP-News: HAEMATO AG / Key word(s): Quarter Results/Quarterly / Interim Statement31.05.2021 / 08:37 The issuer is solely responsible for the content of this announcement.______________________________________________________________________________Corporate News of HAEMATO AG: HAEMATO AG with strong start to the ye...
Patrick Brenske Institute For Drugs Distribution Services Interim Statement Federal Institute Medical Devices

​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021

​​​​​​​PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021 DGAP-News: PAION AG / Key word(s): Quarterly / Interim Statement 12.05.2021 / 07:30 PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER OF 2021 - Remimazolam launches in the U.S. and South Korea in the first quarter of 2021 - EU market approval received for remimazolam in procedural sedation in March 2021 - Good progress in commercialization of remimazolam in...
United Kingdom South Korea Hana Pharm Ralf Penner Jim Phillips Jolla Pharmaceutical Company

PRESS RELEASE: Mutares SE & Co. KGaA: Mutares with strong first quarter 2021 - two acquisitions and two exits

Message : Required fields DGAP-News: Mutares SE & Co. KGaA / Key word(s): Quarter Results/Quarterly / Interim Statement Mutares SE & Co. KGaA: Mutares with strong first quarter 2021 - two acquisitions and two exits 2021-05-11 / 07:25 The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Mutares with strong first quarter 2021 - two acquisitions and two exi...
United Kingdom Poste Italiane Kress Terranor Group Group Cenpa Group Primo Donges Group

EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE

EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE DGAP-News: Evotec SE / Key word(s): Quarter Results/Quarterly / Interim Statement 11.05.2021 / 07:00   SUCCESSFUL START TO 2021 WITH STRONG STRATEGIC POSITION AND LONG-TERM STRATEGY: ACTION PLAN 2025 "THE DATA-DRIVEN R&D AUTOBAHN TO CURES" GOOD PROGRESS WITHIN PRODUCT DEVELOPMENT PARTNERSHIPS AND CO-OWNED PORTFOLIO CONTINUED POSITIVE FINANCIAL PERFORMANCE; NO MATERIAL IMPACT THROUGH COV...
Nordrhein Westfalen United States United Kingdom Volker Braun Evotec Biologics Evotec Group

Taaleri Plc's Interim Statement 1 January–31 March 2021:

Taaleri Plc’s Interim Statement 1 January–31 March 2021: Taaleri sold its wealth management operations and revised its strategy – a strong result in the first quarter On 10 March 2021, Taaleri announced the sale of the wealth management operations to Aktia. Taaleri applies the requirements of IFRS 5 Non-current Assets Held for Sale and Discontinued Operations in the classification, presentation, and recognition of sale of the wealth management operations. January–March 2021, IFRS rep...
Taaleri Plc Interim Statement Interim Statement Assets Held Discontinued Operations இடைக்கால அறிக்கை சொத்துக்கள் கட்டுப்பாட்டில்

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science